IperionX Company Presentation – Scoping Study Update

By: IperionX Limited via Business Wire

July 07, 2022 at 09:00 AM EDT

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

IperionX Limited (“IperionX” or “Company”) (Nasdaq: IPX, ASX: IPX) is pleased to provide a company presentation updated for the results of the recently published Titan Project Scoping Study.

Presentation link: Here

For more information, please visit IperionX's website at: www.iperionx.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20220707005401/en/

Contacts

Anastasios (Taso) Arima, CEO and Managing Director

Dominic Allen, Corporate Development

investorrelations@iperionx.com

+1 980 237 8900

www.iperionx.com

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

More News

AstraZeneca HPP Drug Shows Gains Despite Missing Key Phase III Endpoint ↗

Today 15:02 EDT

Via MarketBeat

First Tracks’ ANB033 Clears Key Phase Ib Celiac Disease Study Goals ↗

Today 13:02 EDT

Via MarketBeat

Salesforce Just Got a Rare Double Upgrade—What Changed? ↗

Today 12:45 EDT

Via MarketBeat

OpenAI's Revenue Scare Could Be a Big Opportunity for Investors ↗

Today 12:05 EDT

Via MarketBeat

MillerKnoll Shareholders Approve Incentive Plan as Fiscal 2026 Sales Rise 5% ↗

Today 12:02 EDT

Via MarketBeat

Recent Quotes

Symbol	Price	Change (%)
AMZN	259.70	-2.73 (-1.04%)
AAPL	339.95	+3.31 (0.98%)
AMD	591.44	-16.66 (-2.74%)
BAC	54.48	+0.16 (0.29%)
GOOG	348.76	+0.90 (0.26%)
META	742.90	+24.23 (3.37%)
MSFT	540.02	+4.95 (0.93%)
NVDA	226.46	-2.82 (-1.23%)
ORCL	136.85	-4.55 (-3.21%)
TSLA	378.19	-4.51 (-1.18%)

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.